Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank58
3Y CAGR-0.4%
5Y CAGR-25.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-0.4%/yr
vs +52.2%/yr prior
5Y CAGR
-25.1%/yr
Recent acceleration
Acceleration
-52.7pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$40.37M-49.5%
2024$80.00M-68.0%
2023$250.01M+511.2%
2022$40.91M+9.3%
2021$37.41M-78.1%
2020$171.13M+63.9%
2019$104.39M+1270.1%
2018$7.62M-24.8%
2017$10.13M-28.7%
2016$14.22M-